Cystic Fibrosis Foundation
Overview
Cystic Fibrosis Foundation is a non-profit organization that provides early-stage funding to companies to develop breakthrough drugs for cystic fibrosis through a venture philanthropy model.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sionna | Mar 2024 | Series C | Co-investor |
| ReCode Therapeutics | Sep 2025 | Venture Round | Co-investor |
| Vast Therapeutics | Jan 2019 | Grant | Co-investor |
| Respirion Pharmaceuticals | Mar 2019 | Series A | Co-investor |
| Gensaic | Jan 2023 | Grant | Lead |
For institutional investors. Book with your work email.
Key People
Bob Derr
Founder Secretary Public Relations
Jennifer McKinnon
Jennifer S Journey Founder President
Laurie Hutchison
Founder Chairperson Destin Great Strides
Eric Koehrsen
Managing Director, Investments
Regina Schewe
Managing Director Major Gifts
Derrick Mueller
Network Leadership Team - Parent Partner
Janeil Whitworth
Cystic Fibrosis Learning Network-Family Patient Partner
Bethany Warren
Senior Strategy Principal
Chris Wirtalla
Senior Principal Data Manager Clinical Data Wrangler
Erin Mellen
Internal Audit Principal
Hillary Valley
Principal, Mission Ventures
Julia Caponiti
Senior Strategy Principal
Lauren Katz
Clinical Program Research Principal
Shelby Murrin
Strategy Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cystic Fibrosis Foundation based?
Cystic Fibrosis Foundation is headquartered in Bethesda, Maryland, United States.
When was Cystic Fibrosis Foundation founded?
Cystic Fibrosis Foundation was founded in 1955.
How many portfolio companies does Cystic Fibrosis Foundation have?
Cystic Fibrosis Foundation has 30 portfolio companies in Caplight's dataset.
What are some companies in Cystic Fibrosis Foundation's portfolio?
Portfolio companies visible on Caplight include Sionna, ReCode Therapeutics, Vast Therapeutics, Respirion Pharmaceuticals, Gensaic.
What was Cystic Fibrosis Foundation's most recent investment shown here?
Cystic Fibrosis Foundation's most recent investment in this portfolio sample was in ReCode Therapeutics in 2025.
What sectors does Cystic Fibrosis Foundation focus on?
Cystic Fibrosis Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Cystic Fibrosis Foundation focus on?
Cystic Fibrosis Foundation typically invests at the MultiStage stage.
What is Cystic Fibrosis Foundation's AUM?
Cystic Fibrosis Foundation's assets under management are estimated between $1.0B and $10.0B.